Operating Profit Margin
since 2005
Calculation
DexCom Inc., operating profit margin, long-term trends, calculation
| Operating profit margin | = | 100 | × | Operating income (loss)1 | ÷ | Revenue1 | |
|---|---|---|---|---|---|---|---|
| Dec 31, 2022 | 13.44% | = | 100 | × | 391,200) | ÷ | 2,909,800) |
| Dec 31, 2021 | 10.86% | = | 100 | × | 265,800) | ÷ | 2,448,500) |
| Dec 31, 2020 | 15.54% | = | 100 | × | 299,500) | ÷ | 1,926,700) |
| Dec 31, 2019 | 9.64% | = | 100 | × | 142,300) | ÷ | 1,476,000) |
| Dec 31, 2018 | -18.06% | = | 100 | × | (186,300) | ÷ | 1,031,600) |
| Dec 31, 2017 | -5.92% | = | 100 | × | (42,500) | ÷ | 718,500) |
| Dec 31, 2016 | -11.15% | = | 100 | × | (63,900) | ÷ | 573,300) |
| Dec 31, 2015 | -14.20% | = | 100 | × | (57,100) | ÷ | 402,000) |
| Dec 31, 2014 | -8.29% | = | 100 | × | (21,500) | ÷ | 259,200) |
| Dec 31, 2013 | -18.06% | = | 100 | × | (28,900) | ÷ | 160,000) |
| Dec 31, 2012 | -55.76% | = | 100 | × | (55,700) | ÷ | 99,900) |
| Dec 31, 2011 | -58.80% | = | 100 | × | (44,843) | ÷ | 76,266) |
| Dec 31, 2010 | -93.13% | = | 100 | × | (45,290) | ÷ | 48,631) |
| Dec 31, 2009 | -154.36% | = | 100 | × | (45,833) | ÷ | 29,693) |
| Dec 31, 2008 | -536.97% | = | 100 | × | (52,827) | ÷ | 9,838) |
| Dec 31, 2007 | -1,008.77% | = | 100 | × | (46,676) | ÷ | 4,627) |
| Dec 31, 2006 | -2,272.76% | = | 100 | × | (49,319) | ÷ | 2,170) |
| Dec 31, 2005 | — | = | 100 | × | (32,430) | ÷ | —) |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$ in thousands
- Revenue Trends
- Revenue exhibits a clear upward trajectory from 2006 through 2022, starting at 2,170 thousand USD in 2006 and increasing steadily to nearly 2,909,800 thousand USD by 2022. This consistent growth reflects significant expansion over the analyzed period, with no years showing decline.
- Operating Income (Loss) Patterns
- Operating income initially registers negative values from 2005 to 2013, indicating operating losses throughout this phase. The losses peak at -186,300 thousand USD in 2018. A marked turnaround occurs starting in 2019, with operating income turning positive and progressively increasing to 391,200 thousand USD by 2022. This shift from persistent losses to substantial profitability highlights a significant improvement in operational efficiency or business scale.
- Operating Profit Margin Analysis
- The operating profit margin mirrors the trends observed in operating income. From 2006 through 2018, margins are negative, although they progressively improve from highly negative extremes such as -2,272.76% in 2006 to around -5.92% in 2017. A notable inflection point appears from 2019 onward, where margins become positive, rising to 13.44% by 2022. This change indicates enhanced cost management or revenue quality, contributing to improved profitability ratios.
- Overall Financial Health Insight
- The data suggest that the company underwent a prolonged period of investment or operational challenges resulting in losses, followed by a successful period of growth and profitability starting around 2019. The positive correlation between rising revenue, improving operating income, and expanding profit margins supports the view of strengthening financial performance. The margins' positive shift suggests that revenue growth has outpaced cost increases in recent years, pointing to sustainable operational improvements.
Comparison to Competitors
DexCom Inc., operating profit margin, long-term trends, comparison to competitors
| DexCom Inc. | Abbott Laboratories | CVS Health Corp. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
|---|---|---|---|---|---|---|
| Dec 31, 2022 | 13.44% | 19.16% | 2.41% | 25.35% | 18.15% | 8.83% |
| Dec 31, 2021 | 10.86% | 19.56% | 4.54% | 31.89% | 14.89% | 8.40% |
| Dec 31, 2020 | 15.54% | 15.48% | 5.19% | 24.09% | 16.57% | 8.76% |
| Dec 31, 2019 | 9.64% | 14.21% | 4.69% | 30.69% | 20.51% | 8.19% |
| Dec 31, 2018 | -18.06% | 11.94% | 2.07% | 32.21% | 22.20% | 7.71% |
| Dec 31, 2017 | -5.92% | 6.30% | 5.15% | 33.71% | 17.94% | 7.60% |
| Dec 31, 2016 | -11.15% | 15.27% | 5.84% | 34.95% | 18.35% | 7.03% |
| Dec 31, 2015 | -14.20% | 14.05% | 6.18% | 31.04% | 18.59% | 7.05% |
| Dec 31, 2014 | -8.29% | 12.84% | 6.31% | 25.56% | 22.42% | 7.92% |
| Dec 31, 2013 | -18.06% | 12.03% | 6.34% | 37.64% | 26.53% | 7.90% |
| Dec 31, 2012 | -55.76% | 20.28% | 5.87% | 40.30% | 0.00% | 8.42% |
| Dec 31, 2011 | -58.80% | 14.81% | 5.91% | 39.54% | 0.00% | 8.36% |
| Dec 31, 2010 | -93.13% | 17.31% | 6.39% | 39.29% | 0.00% | 8.41% |
| Dec 31, 2009 | -154.36% | 20.27% | 6.52% | 35.87% | 0.00% | 7.35% |
| Dec 31, 2008 | -536.97% | 19.28% | 6.91% | 35.53% | 0.00% | 6.54% |
| Dec 31, 2007 | -1,008.77% | 17.67% | 6.28% | 34.41% | 0.00% | 10.57% |
| Dec 31, 2006 | -2,272.76% | 9.09% | 5.57% | 28.81% | 0.00% | 9.88% |
| Dec 31, 2005 | — | 19.53% | 5.46% | 30.25% | 0.00% | 11.98% |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).